Debevoise, Fox Rothschild Rep Lannett In $1.2B Drug Co. Buy
Debevoise & Plimpton LLP and Fox Rothschild LLP steered Philadelphia-based generic-drug maker Lannett Company Inc. in a $1.23 billion deal to acquire the U.S. specialty generic drugs unit of Belgian pharmaceuticals...To view the full article, register now.
Already a subscriber? Click here to view full article